Brugada syndrome in spinal and bulbar muscular atrophy
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: The aim of this study was to clarify myocardial involvement and its clinical implications in subjects with spinal and bulbar muscular atrophy (SBMA), a neuromuscular disease affecting both neuronal and nonneuronal tissues.
Methods: Two independent cardiologists evaluated ECGs from a total of 144 consecutive subjects with SBMA. We performed immunohistochemical, immunoblot, and quantitative real-time PCR analyses of autopsied myocardium.
Results: Abnormal ECGs were detected in 70 (48.6%) of 144 subjects. The most frequent findings were ST-segment abnormalities in V1–3 (19.4%), followed by ST-segment abnormalities in V5–6 (18.1%). We detected Brugada-type ECGs in 17 of 28 subjects with ST-segment abnormalities in V1–3. Of those, one subject presented with syncope that required an implantable cardioverter defibrillator and led to eventual sudden death, and another subject also died suddenly. No subjects with Brugada-type ECGs had mutations in SCN5A, CACNA1C, or CACNB2 genes. In autopsied cases, we detected nuclear accumulation of the mutant androgen receptor protein and decreased expression levels of SCN5A in the myocardium.
Conclusions: Subjects with SBMA often show Brugada-type ECG. The accumulation of the pathogenic androgen receptor may have a role in the myocardial involvement in SBMA.
GLOSSARY
- AR=
- androgen receptor;
- CACNA1C=
- calcium channel, voltage-dependent, L type, α 1C subunit;
- CACNB2=
- calcium channel, voltage-dependent, β 2 subunit;
- GAPDH=
- glyceraldehyde-3-phosphate dehydrogenase;
- HEY2=
- hes-related family bHLH transcription factor with YRPW motif 2;
- SBMA=
- spinal and bulbar muscular atrophy;
- SCN5A=
- sodium channel, voltage-gated, type V, α subunit;
- SCN10A=
- sodium channel, voltage-gated, type X, α subunit
Footnotes
Go to Neurology.org for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Supplemental data at Neurology.org
- Received October 10, 2013.
- Accepted in final form February 19, 2014.
- © 2014 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophyRobert D. Guber, Varun Takyar, Angela Kokkinis et al.Neurology, November 15, 2017 -
Brief Communications
A family with early-onset and rapidly progressive X-linked spinal and bulbar muscular atrophyA. Echaniz-Laguna, E. Rousso, M. Anheim et al.Neurology, April 25, 2005 -
Article
Biomarker-based analysis of preclinical progression in spinal and bulbar muscular atrophyYasuhiro Hijikata, Atsushi Hashizume, Shinichiro Yamada et al.Neurology, March 23, 2018 -
Article
Refining the spinobulbar muscular atrophy phenotype by quantitative MRI and clinical assessmentsJulia R. Dahlqvist, Sofie T. Oestergaard, Nanna S. Poulsen et al.Neurology, January 04, 2019